New! Sign up for our free email newsletter.
Science News
from research organizations

New Theory Of Small Intestinal Bacteria Overgrowth In Nonalcoholic Fatty Liver Disease

Date:
February 22, 2008
Source:
World Journal of Gastroenterology
Summary:
NASH is one type of nonalcoholic fatty liver disease and may develop into hepatic fibrosis and cirrhosis of liver. The pathogenesis of NASH remains unclear. A research group in China has found that small intestinal bacteria overgrowth decreases small intestinal motility in NASH rats.
Share:
FULL STORY

NASH is one type of nonalcoholic fatty liver disease and may develop into hepatic fibrosis and cirrhosis of liver. The pathogenesis of NASH remains unclear. A research group in China has found that small intestinal bacteria overgrowth decreases small intestinal motility in NASH rats.

Small intestinal bacterial overgrowth has been reported to play a role in the pathogenesis of NASH, endotoxin and TNF-A being the possible mediators. Contrary to this hypothesis, in another study, antibiotic treatment did not normalize aminotransferase levels in NASH patients. This article describes an animal experiment of NASH by Dr. Wan-Chun Wu et al.

Dr. Wan-Chun Wu et al* established a NASH animal model by a high fat diet for 12 wks successfully, and treated with cidomycin after 8 wks of the high fat diet. A semi-solid colored marker was used for monitoring small intestinal transit. The proximal small intestine was harvested under sterile condition and processed for quantitation for aerobes (E. coli) and anaerobes (Lactobacilli). Liver pathologic score was calculated to qualify the severity of hepatitis. Serum ALT and AST levels were detected to evaluate the severity of hepatitis.

After 12 wks, they had significant findings. Small intestinal transit was inhibited in NASH group. Rats treated with cidomycin had higher small intestine transit rate than rats in NASH group. The high fat diet resulted in quantitative alterations in the aerobes (E. coli) but not in the anaerobics (Lactobacill). There was an increase in the number of E. coli in the proximal small intestinal flora in NASH group than in control group. TNF-A concentration was significantly higher in NASH group than in control group. TNF-A concentration was lower in cidomycin group than in NASH group. Treatment with cidomycin showed its effect by significantly lowering serum ALT, AST and TNF-A levels of NASH rats. SIBO may decrease small intestinal movement in NASH rats. SIBO may be an important pathogenesis of Nash and treatment with cidomycin by mouth can alleviate the severity of NASH.

The results of this study suggest a promising future for many NASH patients. Due to the high disease incidence of NAFLD around the world and no effective treatment at present, this case reported by Dr. Wan-Chun Wu is surely worth the attention of both doctors and the public at large.

*Journal reference: Wu WC, Zhao W, Li S. Small intestinal bacteria overgrowth decreases small intestinal motility in the NASH rats. World J Gastroenterol 2008 January; 14(2):313-317  http://www.wjgnet.com/1007-9327/14/313.asp


Story Source:

Materials provided by World Journal of Gastroenterology. Note: Content may be edited for style and length.


Cite This Page:

World Journal of Gastroenterology. "New Theory Of Small Intestinal Bacteria Overgrowth In Nonalcoholic Fatty Liver Disease." ScienceDaily. ScienceDaily, 22 February 2008. <www.sciencedaily.com/releases/2008/02/080222101556.htm>.
World Journal of Gastroenterology. (2008, February 22). New Theory Of Small Intestinal Bacteria Overgrowth In Nonalcoholic Fatty Liver Disease. ScienceDaily. Retrieved April 18, 2024 from www.sciencedaily.com/releases/2008/02/080222101556.htm
World Journal of Gastroenterology. "New Theory Of Small Intestinal Bacteria Overgrowth In Nonalcoholic Fatty Liver Disease." ScienceDaily. www.sciencedaily.com/releases/2008/02/080222101556.htm (accessed April 18, 2024).

Explore More

from ScienceDaily

RELATED STORIES